Your session is about to expire
← Back to Search
Internal Brace
MID-C System for Adolescent Idiopathic Scoliosis
N/A
Waitlist Available
Research Sponsored by Apifix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adolescent Idiopathic Scoliosis classified as Lenke Type 1 or Type 5 curves
Must not have
Spinal cord abnormalities that require treatment
Any type of non-idiopathic scoliosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is for a unidirectional expandable rod to be connected to the spine to treat adolescent idiopathic scoliosis. The rod is designed to act as an internal brace. 200 patients will be enrolled in this study.
Who is the study for?
This trial is for adolescents with a specific type of scoliosis called Adolescent Idiopathic Scoliosis. They should have certain curvature angles in their spine, be in good health, and not allergic to titanium. It's not for those who are pregnant, had previous spine surgery that affects the MID-C system use, have poor bone quality or active infections.
What is being tested?
The study tests the safety and benefit of the MID-C System as an internal brace for scoliosis over five years post-implantation. This device connects to the spine at two points and is meant for patients recently implanted following FDA approval.
What are the potential side effects?
While specific side effects aren't listed here, similar devices may cause pain at the implant site, possible infection risk, potential impact on spinal growth or movement due to being an internal brace.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My scoliosis is classified as Lenke Type 1 or 5.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need treatment for my spinal cord abnormalities.
Select...
I have a type of scoliosis that is not idiopathic.
Select...
I have a spine or chest shape issue that affects my upper back.
Select...
I have an infection or damaged skin where surgery is planned.
Select...
I am not pregnant.
Select...
I've had spine surgery that may interfere with MID-C system procedures.
Select...
I have a weakness in my muscles.
Select...
I do not have active AIDS, HIV, or any ongoing infections.
Select...
I have a history of cancer or a current infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Maintenance of major Cobb angle ≤ 40° 5 years post-surgery
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MID-C treatmentExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
ApifixLead Sponsor
6 Previous Clinical Trials
82 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am in good overall health.You do not have any known allergies or sensitivities to titanium.I need treatment for my spinal cord abnormalities.I have a type of scoliosis that is not idiopathic.I have a spine or chest shape issue that affects my upper back.I have an infection or damaged skin where surgery is planned.I am a suitable candidate for surgery from the back.I am not pregnant.I've had spine surgery that may interfere with MID-C system procedures.I do not have any other illnesses that could worsen my health or affect the study results.I have a weakness in my muscles.I do not have active AIDS, HIV, or any ongoing infections.this agrees with Cobb angle measurements
Kyphosis angles measured from T5 to T12 are less than or equal to 55 degrees; this agrees with Cobb angle measurements.My scoliosis is classified as Lenke Type 1 or 5.I have a history of cancer or a current infection.You are generally healthy.
Research Study Groups:
This trial has the following groups:- Group 1: MID-C treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger